Emergency Medicine Doctors in Tripler Amc, HI Accepting Medicare

8 Emergency Medicine doctors found. Showing 1 - 8

Ross Graham, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Jarrett White Rd, Tripler Amc, HI 96859 Phone: 808-433-6864

Nathan Kwon, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center Attn: Mchk-qs, Tripler Amc, HI 96859 Phone: 808-433-2460    Fax: 808-433-1558

Dr. Peter Bulkley Woollett, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, Tripler Amc, HI 96859 Phone: 808-433-2460    Fax: 808-433-1558

Dr. Douglas Jerome Waffen, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, Tripler Amc, HI 96859 Phone: 808-433-2460    Fax: 808-433-1558

Dr. John Edward Mallon, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center Attn:mchk-qs, Tripler Amc, HI 96859 Phone: 808-433-2460    Fax: 808-433-1558

Juan R Perez, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Amc, HI 96859 Phone: 808-728-2411

Dr. Mary Kathryn Montgomery, DO Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Amc, HI 96859 Phone: 808-433-5151

Christopher Falslev, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Jarrett White Rd, Tripler Amc, HI 96859 Phone: 808-433-5551

News Archive

Artificial intelligence can help accurately predict acute kidney injury in burn patients

Many burn victims suffer acute kidney injury (AKI), but early recognition of AKI remains challenging. Now an Artificial Intelligence / Machine Learning (AI/ML) model developed at UC Davis Health and reported in a new study can predict acute kidney injury quicker and more accurately than ever.

Study demonstrates new therapeutic targets for inflammation-associated colon cancer

Scientists headed by ICREA researcher Angel R. Nebreda at the Institute for Research in Biomedicine (IRB Barcelona) report a new mechanism that contributes to the development of inflammation-associated colon cancer and points to new therapeutic targets. The study has been published in the journal EMBO Molecular Medicine.

Ceragenix Pharmaceuticals updates license agreement covering antimicrobial technology use

Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive evaluation and option to license agreement (the "Agreement") with a global, multi-billion dollar healthcare company covering the use of the Company's CeraShield antimicrobial technology for a specific medical device associated with a high incidence of hospital acquired infections.

Gabriel Hortobagyi recognized with AACR-MICR Jane Cooke Wright Lectureship

Gabriel Hortobagyi, M.D., professor in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, will receive the Jane Cooke Wright Lectureship from the American Association for Cancer Research and its Minorities in Cancer Research membership group.

Chemo-radiotherapy combination a viable alternative for frail bladder cancer patients

Bladder cancer patients given low doses of chemotherapy combined with radiotherapy were nearly 50 per cent less likely to relapse with the most lethal form of the disease compared to those given radiotherapy alone, a major trial funded by Cancer Research UK shows.

Read more Medical News

› Verified 1 days ago